Diabetes

A review of 41 trials finds only two assessed dietary intake with GLP 1 receptor agonists, underscoring a critical gap in nutrition research.

GLP-1RAs are associated with a reduced risk of aneurysmal rupture in high-risk patient populations, a 2026 study has found.

Tirzepatide proves superior to semaglutide in weight reduction and improving glycaemic indices, a 2026 network meta-analysis has found.

Maternal diabetes is associated with an increased epilepsy risk in offspring, a 2026 cohort study has found.

Gut microbiota dysbiosis might contribute to the development of diabetic retinopathy through the gut-eye axis, according to a 2026 systematic review and meta-analysis.

The UK’s MHRA has strengthened warnings of acute pancreatitis on GLP-1RAs, following rare reports of necrotising and fatal pancreatitis.

New data show GLP-1 RAs lower amputation, cardiovascular, and mortality risks in diabetes patients with prior limb events.

Using univariate and multivariate logistic regression, the investigators identified eight independent predictors of thyroid dysfunction.